Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biora Therapeutics Inc 4330 LA JOLLA VILLAGE DRIVE SUITE 300 SAN DIEGO CA 92122 USA

www.bioratherapeutics.com P: 833-727-2841 F: 248-848-1623

Description:

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 36,188
Enterprise Value, $K 5,698
Shares Outstanding, K 27,209
Annual Sales, $ 310 K
Annual Net Income, $ -38,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -73,450 K
EBIT, $ -67,570 K
EBITDA, $ -65,240 K
60-Month Beta 1.11
% of Insider Shareholders 23.18%
% of Institutional Shareholders 43.74%
Float, K 20,902
% Float 76.82%
Short Volume Ratio 0.55

Growth:

1-Year Return -56.18%
3-Year Return -99.05%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.75 on 11/13/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -5.42
EPS Growth vs. Prev Qtr 48.98%
EPS Growth vs. Prev Year 62.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 01/03/23

BIOR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -125.67%
Profit Margin % -12,309.68%
Debt/Equity 0.00
Price/Sales 756.29
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -5.07
Interest Coverage -3.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar